Colorado-based kidney-care company DaVita has agreed to pay about $34.5 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce referrals to DaVita Rx, a former subsidiary that provided pharmacy services for dialysis patients, according to the U.S. Department of Justice.